Division of Abdominal Tumor Multimodality Treatment, Cancer Center and Lab of Experimental Oncology, State Key Laboratory of Biotherapy, and Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China.
Anal Chim Acta. 2024 Oct 16;1326:342978. doi: 10.1016/j.aca.2024.342978. Epub 2024 Jul 15.
Phage display is a vital tool for the discovery and development of affinity reagents such as antibodies and peptides, which have great potential in imaging, molecular recognition, biosensors, targeted delivery and other clinical applications. However, affinity reagents obtained by phage display are often subjected to a process called biopanning, which is considered time-consuming, labor-intensive and lacks accurate control, limiting the acquisition of high-quality affinity reagents. Over the last two decades, several microfluidic approaches have been designed to simplify the conventional biopanning process and to realize precise control. To better understand the advantages of microfluidics over traditional biopanning and the potential of microfluidics for other molecular screening strategies, we provided an overview of recent applications of microfluidics in phage display. Additionally, the next challenges and outlooks are discussed.
噬菌体展示是发现和开发亲和试剂(如抗体和肽)的重要工具,这些亲和试剂在成像、分子识别、生物传感器、靶向输送和其他临床应用中具有巨大的潜力。然而,噬菌体展示获得的亲和试剂通常需要经过一个称为生物淘选的过程,该过程被认为耗时、费力且缺乏精确控制,限制了高质量亲和试剂的获取。在过去的二十年中,已经设计了几种微流控方法来简化传统的生物淘选过程并实现精确控制。为了更好地理解微流控相对于传统生物淘选的优势以及微流控在其他分子筛选策略中的潜力,我们综述了微流控在噬菌体展示中的最新应用。此外,还讨论了未来的挑战和展望。